Orion Corporation: Change in Orion Group Executive Management Board as of 31 May 2025
07 Maggio 2024 - 7:30AM
Orion Corporation: Change in Orion Group Executive Management Board
as of 31 May 2025
ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES BOARD /
MANAGEMENT / AUDITORS7 May 2024 at 08.30 EEST
Orion
Corporation: Change in Orion Group Executive Management Board as of
31 May 2025
Olli Huotari, Senior Vice President responsible
for Corporate Functions organization (including, i.a.,
Communications, Compliance, Corporate Responsibility, Intellectual
Property Rights, Legal Affairs and Public Affairs) of the
Orion Group and Secretary to the Board of Directors of Orion
Corporation, and a member of the Executive Management Board of the
Orion Group has informed the company of his decision to leave
Orion. Orion will start a recruiting process of the successor to
Olli Huotari. In order to secure a proper transition of
responsibilities to his successor, Orion and Huotari have agreed
that Huotari will continue in his current positions at Orion
(including the membership of the Executive Management Board of
the Orion Group) until 31 May 2025, after which he will leave the
company.
Olli Huotari has held group-level leadership positions at Orion
since 2002.
President and CEO Liisa Hurme says:
“I want to warmly thank Olli for his great work for Orion. It is
of course a pity when such a proficient and experienced leader
wants to leave. However, as much as we would like to keep him with
the company, we must respect his decision. We are pleased that Olli
has agreed to continue working at Orion for a sufficient period in
order to ensure a smooth transition of responsibilities and
introduction of his successor. This also reflects Olli as a person
− he always wants to make sure that the company’s interests are
taken care of.”
Olli Huotari says:“I have always appreciated and been very
grateful for all the positions and career Orion has offered to me.
Orion is a great company with great people. Until the end of May
2025, I will continue working for the company and will do my best
so that my successor will have the best possible start in the new
position. After that, I will move to the next phase of my
life.”
Orion Corporation
| Liisa
HurmePresident and CEO |
|
Terhi OrmioVice
President, Communications |
|
Contact
person:Liisa HurmePresident and CEOtel. +358 50 966
2874
Contact person for the media:Terhi Ormio, Vice
President, Communicationstel. +358 50 966
4646terhi.ormio@orion.fi
Publisher:Orion
CorporationCommunicationsOrionintie 1A, FI-02200 Espoo,
Finlandhttp://www.orion.fi/en
http://www.twitter.com/OrionCorpIR
Orion is a globally operating Finnish pharmaceutical company – a
builder of well-being. We develop, manufacture and market human and
veterinary pharmaceuticals and active pharmaceutical ingredients.
Orion has an extensive portfolio of proprietary and generic
medicines and consumer health products. The core therapy areas of
our pharmaceutical R&D are oncology and pain. Proprietary
products developed by Orion are used to treat cancer, neurological
diseases and respiratory diseases, among others. Orion's net sales
in 2023 amounted to EUR 1,190 million and the company had about
3,600 employees at the end of the year. Orion's A and B shares are
listed on Nasdaq Helsinki.
Grafico Azioni Orion (BIT:1ORNBV)
Storico
Da Mar 2025 a Apr 2025
Grafico Azioni Orion (BIT:1ORNBV)
Storico
Da Apr 2024 a Apr 2025
